Cargando…
Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status
Small-cell lung cancer (SCLC) is highly sensitive to platinum-based chemotherapy. However, its indication in patients with a poor performance status (PS) at initial diagnosis is controversial. We retrospectively reviewed all clinical courses of pathologically diagnosed SCLC patients with poor PS, Ea...
Autores principales: | Aida, Yuka, Nakazawa, Kensuke, Shiozawa, Toshihiro, Ogawa, Ryoko, Kiwamoto, Takumi, Morishima, Yuko, Sakamoto, Toru, Sekine, Ikuo, Hizawa, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738152/ https://www.ncbi.nlm.nih.gov/pubmed/31543777 http://dx.doi.org/10.1159/000501548 |
Ejemplares similares
-
Rechallenge with First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
por: Shiozawa, Toshihiro, et al.
Publicado: (2018) -
Negative-pressure pulmonary Hemorrhaging Due to Severe Obstructive Sleep Apnea
por: Kuramoto, Kenya, et al.
Publicado: (2021) -
Pasteurella multocida pneumonia with hemoptysis: A case report
por: Aida, Yuka, et al.
Publicado: (2018) -
Long‐term outcomes of high‐dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer
por: Ohnishi, Kayoko, et al.
Publicado: (2021) -
Has2 Regulates the Development of Ovalbumin-Induced Airway Remodeling and Steroid Insensitivity in Mice
por: Sherpa, Mingma Thsering, et al.
Publicado: (2022)